Yu Deng

Active 1995–2026

658
Papers
44,764
Citations
96
h-index
463
i10-index

Citations

Citations per year for Yu Deng1955: 1 citations1971: 1 citations1989: 1 citations1991: 1 citations1994: 1 citations1995: 1 citations1996: 4 citations1997: 1 citations1998: 18 citations1999: 35 citations2000: 41 citations2001: 33 citations2002: 37 citations2003: 26 citations2004: 37 citations2005: 37 citations2006: 68 citations2007: 99 citations2008: 115 citations2009: 101 citations2010: 130 citations2011: 136 citations2012: 122 citations2013: 118 citations2014: 103 citations2015: 129 citations2016: 149 citations2017: 172 citations2018: 223 citations2019: 891 citations2020: 1,664 citations2021: 1,847 citations2022: 1,893 citations2023: 1,802 citations2024: 2,702 citations2025: 2,008 citations2026: 502 citations1956–1970: no citations, so these years are not shown1972–1988: no citations, so these years are not shown1990: no citations, so this year is not shown1992–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 5,829 citing papers, 29.3% of this breakdownUnited States: 3,421 citing papers, 17.2% of this breakdownUnited Kingdom: 834 citing papers, 4.2% of this breakdownItaly: 705 citing papers, 3.5% of this breakdownGermany: 660 citing papers, 3.3% of this breakdownJapan: 636 citing papers, 3.2% of this breakdownCanada: 602 citing papers, 3% of this breakdownFrance: 568 citing papers, 2.8% of this breakdownIndia: 512 citing papers, 2.6% of this breakdownSpain: 487 citing papers, 2.4% of this breakdownSouth Korea: 419 citing papers, 2.1% of this breakdownAustralia: 389 citing papers, 2% of this breakdown
0%29.3%Other 24.4%

Fields

  • Medicine37.9%
  • Biochemistry, Genetics and Molecular Biology23.7%
  • Computer Science11.9%
  • Engineering7.8%
  • Neuroscience4.4%
  • Materials Science3.3%
  • Other11%

Topics

  • Cancer Immunotherapy and Biomarkers5.3%
  • Lung Cancer Treatments and Mutations3.1%
  • Lung Cancer Research Studies2.3%
  • RNA modifications and cancer1.9%
  • Cancer-related molecular mechanisms research1.6%
  • Lung Cancer Diagnosis and Treatment1.6%
  • Other84.2%

Coauthors

All papers

Open in search
  1. CogACT: A Foundational Vision-Language-Action Model for Synergizing Cognition and Action in Robotic Manipulation

    Authors: , , , , , , , , , , , , , , , , , - arXiv (Cornell University), CoRR 2024 cited by 327

  2. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 3,753

  3. Structured 3D Latents for Scalable and Versatile 3D Generation

    Authors: , , , , , , , , - IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2025 cited by 282

  4. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 1,479

  5. Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,691

  6. Deep Learning in Human Activity Recognition with Wearable Sensors: A Review on Advances

    Authors: , , , , , , , , - Sensors 2022 cited by 489

  7. Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 824

  8. MoGe-2: Accurate Monocular Geometry with Metric Scale and Sharp Details

    Authors: , , , , , , , , - NeurIPS 2025 cited by 123

  9. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade

    Authors: , , , , , , , , , , - Nature Communications 2019 cited by 817

  10. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian A. Thomas, Fabrice Barlési, Gene Finley, Anthony Lee, Shelley Coleman, Yu Deng, Marcin Kowanetz, Geetha Shankar, Wei Lin, Mark A Socinski - The Lancet Respiratory Medicine 2019 cited by 939

  11. MoGe: Unlocking Accurate Monocular Geometry Estimation for Open-Domain Images with Optimal Training Supervision

    Authors: , , , , , , - IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2025 cited by 58

  12. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease

    Authors: , , , , , , , , - The International Journal of Neuropsychopharmacology 2011 cited by 424

  13. Mitochondrial quality control in human health and disease

    Authors: , , , , , , , , , , - Military Medical Research 2024 cited by 145

  14. Uridine Alleviates Sepsis-Induced Acute Lung Injury by Inhibiting Ferroptosis of Macrophage

    Authors: , , , , , , - International Journal of Molecular Sciences 2023 cited by 148

  15. The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019

    Authors: , , , , , , - BMC Public Health 2022 cited by 168

  16. Exosome/antimicrobial peptide laden hydrogel wound dressings promote scarless wound healing through miR-21-5p-mediated multiple functions

    Authors: , , , , , , , , - Biomaterials 2024 cited by 99

  17. Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice

    Authors: , , - Journal of Visualized Experiments 2011 cited by 587

  18. Surface-Enhanced Raman Scattering Active Gold Nanoparticles with Enzyme-Mimicking Activities for Measuring Glucose and Lactate in Living Tissues

    Authors: , , , , , , , , , , , , , - ACS Nano 2017 cited by 622

  19. Enzyme‐Mediated Tumor Starvation and Phototherapy Enhance Mild‐Temperature Photothermal Therapy

    Authors: , , , , , , , , , , , , , , , , - Advanced Functional Materials 2020 cited by 322

  20. Natural Language Processing for EHR-Based Computational Phenotyping

    Authors: , , , , - IEEE/ACM Transactions on Computational Biology and Bioinformatics, IEEE ACM Trans. Comput. Biol. Bioinform. 2018 cited by 219

  21. Development of a growth coupled and multi-layered dynamic regulation network balancing malonyl-CoA node to enhance (2S)-naringenin biosynthesis in Escherichia coli

    Authors: , , , , , - Metabolic Engineering 2021 cited by 118

  22. CD44 splice isoform switching determines breast cancer stem cell state

    Authors: , , , , , , , , , , , , , - Genes & Development 2019 cited by 229

  23. Gut microbiome and cancer immunotherapy

    Authors: , , , - Cancer Letters 2019 cited by 248

  24. Trident Molecule with Nanobrush–Nanoparticle–Nanofiber Transition Property Spatially Suppresses Tumor Metastasis

    Authors: , , , , , , , , - Journal of the American Chemical Society 2022 cited by 94